Method of treating rheumatoid arthritis using tetracycline

Details Method of treating rheumatoid arthritis using tetracycline Method of treating rheumatoid arthritis using tetracycline

1993-04-08

1993-10-05

Waddell, Frederick E.

Chemistry: analytical and immunological testing

For preexisting immune complex or auto-immune disease

Rheumatoid factors

514152, 514825, G01N 33564, A61K 3165

Patent

active

052504425

ABSTRACT:
A method of treating rheumatoid arthritis which includes first, taking a blood test to determine a rate of erythrocyte sedimentation and a rheumatoid factor, and then fasting for a 12-hour period prior to orally administering a 500 milligram dosage of tetracycline achromycin, and observing any change in the symptoms of the rheumatoid arthritis including reduction of swelling and pain in the affected sites. This process is repeated over 24-hour cycles until the rheumatoid factor has decreased by at least 50% from the first determined level prior to treatment and erythrocyte sedimentation decreased, at which point the 24-hour cycles are continued, reducing the dosage of tetracycline achromycin to 250 milligrams until the symptoms of the rheumatoid arthritis condition disappear.

REFERENCES:
Dialoge Medicine File Abst. 90189067 (1990).

Affiliated with

Also associated with

Rating

Method of treating rheumatoid arthritis using tetracycline does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating rheumatoid arthritis using tetracycline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating rheumatoid arthritis using tetracycline will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1003220